PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single-dose study to evaluate the PK profile of the liquid SC
formulation of BIO89-100 in approximately 8 male and female subjects with NASH with
compensated cirrhosis.